ResMed - 24 Year Stock Price History | RMD

Historical daily share price chart and data for ResMed since 1995 adjusted for splits. The latest closing stock price for ResMed as of September 17, 2019 is 133.93.
  • The all-time high ResMed stock closing price was 140.33 on September 05, 2019.
  • The ResMed 52-week high stock price is 141.25, which is 5.5% above the current share price.
  • The ResMed 52-week low stock price is 90.64, which is 32.3% below the current share price.
  • The average ResMed stock price for the last 52 weeks is 112.45.
ResMed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 114.2392 111.7700 140.3300 91.5600 133.9300 17.62%
2018 103.1508 85.5300 115.5500 85.5300 113.8700 34.46%
2017 74.9645 61.9500 86.4400 61.8700 84.6900 36.49%
2016 60.8889 52.2100 70.6700 51.4000 62.0500 15.57%
2015 59.4875 57.1700 74.8200 49.4300 53.6900 -4.23%
2014 49.4595 46.2000 57.3900 42.0300 56.0600 19.07%
2013 47.7458 42.4800 57.1100 42.3600 47.0800 13.25%
2012 34.3121 25.6100 42.7700 24.8100 41.5700 63.66%
2011 30.0974 35.0200 35.2800 23.4600 25.4000 -26.67%
2010 31.3773 26.3950 35.6100 25.2750 34.6400 32.54%
2009 21.1631 19.1900 26.5350 15.9100 26.1350 39.46%
2008 20.2211 25.6550 25.6550 14.9150 18.7400 -28.65%
2007 22.6923 25.0350 27.1300 19.8250 26.2650 6.72%
2006 21.7403 19.1100 25.5400 18.4300 24.6100 28.48%
2005 16.6809 12.7025 21.3600 12.4525 19.1550 49.94%
2004 11.8786 10.5000 12.8900 10.1725 12.7750 23.01%
2003 9.5775 7.7625 11.6225 7.4175 10.3850 35.88%
2002 8.3725 13.2875 13.2875 6.1750 7.6425 -43.30%
2001 12.5122 9.8450 15.4375 9.1650 13.4800 35.21%
2000 7.7250 5.1100 10.3750 5.0863 9.9700 91.04%
1999 4.1728 5.3438 6.4300 2.4688 5.2188 -8.00%
1998 2.8117 1.7500 5.9063 1.7500 5.6725 222.76%
1997 1.4750 1.3438 1.9375 1.0625 1.7575 27.82%
1996 1.0090 0.7500 1.4375 0.6563 1.3750 69.23%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $18.992B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00